Literature DB >> 1311287

Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells.

L Lehtola1, J Partanen, L Sistonen, J Korhonen, A Wärri, P Härkönen, R Clarke, K Alitalo.   

Abstract

The MCF-7 cell line is a hormone-responsive human breast-cancer cell line, which has been extensively used in studies of estrogen regulation of cell growth. These studies have indicated that the growth stimulation of the MCF-7 cells by estrogens may be effected by an autocrine mechanism involving several growth factors, such as EGF, TGF alpha and IGF-I and their receptors. We have amplified and cloned tyrosine-kinase-related sequences from the MCF-7 cell mRNA using the polymerase chain reaction and characterized the partial cDNAs obtained by nucleic acid sequencing. Nine tyrosine kinase cDNAs and one serine/threonine kinase cDNA were identified among the amplified sequences. Four different tyrosine kinase genes encoding receptors for fibroblast growth factors (FGFs) were found to be expressed by the MCF-7 cells. In addition, differences were observed in the expression of these members of FGF receptor family in different breast-cancer cells. A putative tyrosine-kinase receptor and a novel serine/threonine kinase were preferentially expressed in estrogen-responsive tumor cell lines. However, no estrogen-dependent regulation of any of the novel tyrosine-kinase receptor mRNAs was found in any of the cell lines including the MCF-7 or ZR-75-I cells, where the expression of the neu proto-oncogene mRNA was decreased during estrogen treatment. The expression of several FGF receptors by breast-cancer cells suggests that FGFs may be involved in their growth regulation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311287     DOI: 10.1002/ijc.2910500419

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.

Authors:  Lan Ma; Haifeng Zhang; Carrie Han; Danian Tong; Meiyan Zhang; Yi'an Yao; Yu Luo; Xuebo Liu
Journal:  DNA Cell Biol       Date:  2012-02-07       Impact factor: 3.311

2.  bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement.

Authors:  C L Johnston; H C Cox; J J Gomm; R C Coombes
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

3.  Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.

Authors:  Zhanshan Cha; Yan Zang; Huijun Guo; Haihui Gu; Xiaohua Tu; Haihan Song; Baohua Qian
Journal:  Mol Biol Rep       Date:  2014-01-01       Impact factor: 2.316

4.  Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study.

Authors:  Qing Zhu; Tongtao Liu
Journal:  Mol Biol Rep       Date:  2012-06-14       Impact factor: 2.316

5.  Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis.

Authors:  Woo Sung Moon; Ho Sung Park; Ki Hoon Yu; Kyu Yun Jang; Myoung Jae Kang; Harry Park; Andrzej S Tarnawski
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

6.  Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.

Authors:  Lei Gao; Zhenjun Feng; Qiang Li; Lianqing Li; Lei Chen; Taiwu Xiao
Journal:  Tumour Biol       Date:  2013-11-19

Review 7.  eph, the largest known family of putative growth factor receptors.

Authors:  N L Tuzi; W J Gullick
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

8.  Expression of keratinocyte growth factor and its receptor in human breast cancer.

Authors:  G S Bansal; H C Cox; S Marsh; J J Gomm; C Yiangou; Y Luqmani; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Down-regulation of a novel form of fibroblast growth factor receptor 1 in human breast cancer.

Authors:  C Yiangou; H Cox; G S Bansal; R Coope; J J Gomm; R Barnard; J Walters; N Groome; S Shousha; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues.

Authors:  Y A Luqmani; M Graham; R C Coombes
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.